News • Politics

EIBIR launches its Strategic Research Agenda for Biomedical Imaging

The European Institute for Biomedical Imaging Research (EIBIR) has published its Strategic Research Agenda (SRA) for Biomedical Imaging. The agenda identifies current challenges and needs in healthcare, illustrating how biomedical imaging and derived data can help to address these challenges, in order to stimulate dedicated research funding efforts and mechanisms.

Photo

The SRA was developed in collaboration with EIBIR`s shareholders representing scientific societies related to biomedical imaging, as well as EIBIR's Scientific Advisory Board. It identifies and describes five main challenges facing biomedical imaging today, and addresses in detail how these challenges can be overcome.

In particular, the agenda addresses the current paradigm shift in medicine and healthcare, which has moved from a reactive to proactive approaches and solutions by providing predictive, preventive, and personalised medical solutions for the individual patient. It highlights the growing impact of personalised medicine on patients and its ability to address the challenges of ineffective treatment and rising healthcare costs. The SRA also focusses on the growing importance of big data, artificial intelligence, and innovative imaging technologies, emphasising biomedical imaging’s role as a forerunner in the digital transformation of healthcare and as a leading discipline in the adoption of new innovative solutions like deep learning and artificial intelligence.

EIBIR is a nonprofit organisation founded by the European Society of Radiology and supports researchers and industry partners in the preparation and coordination of biomedical imaging research projects throughout Europe. EIBIR comprises a large and diverse landscape of more than 130 network members (universities, hospitals and research organisations) and is committed to supporting the development of biomedical imaging technologies and to the disseminating of knowledge with the ultimate goal of improving the diagnosis, treatment, and prevention of disease.

Through its Strategic Research Agenda for Biomedical Imaging, EIBIR hopes to stimulate and direct funding efforts towards research projects and developments which will address some of the most important challenges facing healthcare in Europe and the rest of the world.

You can read the Strategic Research Agenda for Biomdical Imaging here.

Source: ESR Press Office

08.10.2018

Read all latest stories

Related articles

Photo

News • Nuclear medicine

Prostate cancer: staging issues in bone scans compared with PSMA PET

Bone scans have been found to overstage prostate cancer at initial staging compared to prostate specific membrane antigen (PSMA) PET, according to new research.

Photo

News • Chest X-ray evaluation

Human readers still outperform AI in lung disease identification

Reports of AI gaining the upper hand in diagnostic imaging interpretation are piling up, but there are still areas where the eye of a trained human radiologist remains superior.

Photo

News • Imaging for targeted biopsy

MRI and ultrasound "fusion" improves prostate cancer detection

Combining ultrasound and MRI technology can help detect prostate cancer at an earlier stage and potentially save lives, according to new University of Dundee research.

Related products

2-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 2-part PMMA CT-Phantom

IBA Dosimetry GmbH
3-part PMMA CT-Phantom

Testing Devices

IBA Dosimetry · 3-part PMMA CT-Phantom

IBA Dosimetry GmbH
Accutron CT

Injectors

Medtron AG · Accutron CT

MEDTRON AG
Accutron HP

Injectors

Medtron AG · Accutron HP

MEDTRON AG
Subscribe to Newsletter